Performance analysis of Champions Oncology (CSBR)
Annual Return
Over the past 3 years, CSBR has had an average annual return of +3.21%, underperforming the benchmark SPY, which returned +22.77% annual.
Over the past 5 years, CSBR has had an average annual return of -10.20%, underperforming the benchmark SPY, which returned +14% annual.
Over the past 10 years, CSBR has had an average annual return of +7.86%, underperforming the benchmark SPY, which returned +15.53% annual.
Since Feb 2, 2007, CSBR has had an average annual return of -1.15%, underperforming the benchmark SPY, which returned +10.97% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -16.64% | -19.37% | +52.50% | +24.60% | -46.05% | -22.52% | +29.54% | +6.66% | +101.28% | +53.36% | -29.12% | -40.50% |
| 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | ||||
| -58.34% | +300% | -60.00% | -16.67% | +12.50% | -25.93% | -22.86% | +133.33% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +5.79% | -18.54% | -3.45% | +3.66% | -2.10% | -1.28% | -16.64% | ||||||
| 2025 | +28.24% | -6.46% | -15.56% | -17.63% | -17.90% | +25.55% | -14.24% | +7.59% | -4.78% | +5.64% | -4.39% | +5.66% | -19.37% |
| 2024 | +3.38% | +1.55% | -16.94% | -1.03% | -6.59% | +14.13% | -7.35% | -11.90% | +15.41% | -19.71% | +15.60% | +89.60% | +52.50% |
| 2023 | -8.88% | +13.14% | -13.55% | +22.39% | +5.90% | +22.46% | +1.88% | +3.08% | -7.32% | -12.08% | -5.67% | +9.12% | +24.60% |
| 2022 | -4.07% | -2.12% | +3.57% | -5.53% | -3.65% | +8.10% | +8.25% | -7.86% | -6.01% | -7.47% | -0.58% | -34.63% | -46.05% |
| 2021 | +1.76% | +6.37% | -3.25% | -5.04% | -12.31% | +9.25% | +1.65% | -7.28% | +5.37% | -4.32% | -18.93% | +5.55% | -22.52% |
| 2020 | -8.88% | -17.00% | +17.46% | +4.32% | +24.74% | -0.73% | -8.58% | -5.26% | +11.71% | -5.08% | +29.51% | -5.10% | +29.54% |
| 2019 | +56.60% | -4.99% | -15.75% | -7.25% | +3.08% | -16.35% | -17.37% | -16.54% | +4.63% | -7.43% | +10.13% | +44.61% | +6.66% |
| 2018 | -1.54% | -9.18% | +4.92% | +19.09% | +6.81% | +36.93% | +26.18% | +10.25% | +98.07% | -29.14% | +2.34% | -38.36% | +101.28% |
| 2017 | +87.73% | -27.36% | -8.12% | -16.40% | -9.07% | +6.63% | +10.51% | +6.69% | +21.13% | -12.81% | +12.20% | +8.08% | +53.36% |
Drawdown analysis of Champions Oncology (CSBR)
The maximum drawdown for the CSBR was -94.13%, occurring on Sep 16, 2016. This drawdown has not yet recovered.
The current CSBR drawdown is -77.14%.
Since Feb 2, 2007 CSBR has experienced the following drawdowns:
- 50% or more: 2 times
- 40% or more: 2 times
- 30% or more: 3 times
- 20% or more: 3 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -94.13% | Oct 24, 2007 | 2240 | Sep 16, 2016 | Ongoing | Ongoing | Ongoing |
| -58.33% | Feb 2, 2007 | 4 | Feb 8, 2007 | 77 | May 31, 2007 | 81 |
| -35.72% | Jun 1, 2007 | 31 | Jul 17, 2007 | 60 | Oct 10, 2007 | 91 |
| -12.71% | Oct 18, 2007 | 1 | Oct 19, 2007 | 2 | Oct 23, 2007 | 3 |